Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials

Authors: Zonglin Li, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Source: Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-16 (2024)

Subject Terms: Anti-diabetic agents, Dementia, Alzheimer’s disease, Sodium-glucose cotransporter-2 inhibitor, Glucagon-like peptide-1 receptor agonist, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://doaj.org/toc/1758-9193

Access URL: https://doaj.org/article/b70a8acd3c7448a6948fd50efb1597fb

Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial

Authors: Teerapat Nantsupawat, Nattayaporn Apaijai, Arintaya Phrommintikul, Narawudt Prasertwitayakij, Siriporn C. Chattipakorn, Nipon Chattipakorn, Wanwarang Wongcharoen

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

Subject Terms: Sodium-glucose Cotransporter-2 inhibitor, Arrhythmias, Atrial fibrillation, Cardiovascular Implantable Electronic device, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/da6857d7a3214afe9f2693f3acbceaf1

Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease

Authors: M. Soulié, Y. Stephan, M. Durand, I. Lima-Posada, R. Palacios-Ramírez, L. Nicol, N. Lopez-Andres, P. Mulder, F. Jaisser

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)

Subject Terms: Cardiorenal, Chronic kidney disease, Mineralocorticoid receptor antagonist, Sodium-glucose cotransporter-2 inhibitor, 5/6 nephrectomy, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/15f1b047b07849c4b85225bbf161495d

Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes

Authors: Muhammad Shahzeb Khan, Janice P. Lea

Source: BMC Nephrology, Vol 25, Iss 1, Pp 1-14 (2024)

Subject Terms: Chronic kidney disease, Combination therapy, Finerenone, Sodium-glucose cotransporter-2 inhibitor, Glucagon-like peptide-1 receptor agonist, Diseases of the genitourinary system. Urology, RC870-923

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2369

Access URL: https://doaj.org/article/d150c7a24bb44447a794c83bcf72ab52

Clinical efficacy of SGLT-2 inhibitor for heart failure after PCI in STEMI patients

Authors: ABUDURUSULI Kadier, LI Jie, WANG Zhao

Source: Xin yixue, Vol 55, Iss 8, Pp 624-630 (2024)

Subject Terms: sodium-glucose cotransporter-2 inhibitor, heart failure, st-segment elevation myocardial infarction, percutaneous coronary intervention, readmission risk, Medicine

File Description: electronic resource

Relation: https://www.xinyixue.cn/fileup/0253-9802/PDF/1726710486555-467691383.pdf; https://doaj.org/toc/0253-9802

Access URL: https://doaj.org/article/1ba843be6ac849f98cc1967f7ef7d614

Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography

Authors: Tianhao Zhang, Xuelian Gao, Tianlong Chen, Hongkai Zhang, Xiaoming Zhang, Yu Xin, Dongmei Shi, Yu Du, Lei Xu, Yujie Zhou

Source: Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-13 (2024)

Subject Terms: Atherosclerotic plaque, Type 2 diabetes mellitus, Coronary computed tomography angiography, Sodium-Glucose Cotransporter-2 Inhibitor, Longitudinal study, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/1475-2840

Access URL: https://doaj.org/article/4c9452ecb10d45bb956c25517c43325d

Effect of early application of a sodium-glucose cotransporter-2 inhibitor on ventricular remodelling and prognosis in patients with anterior wall acute myocardial infarction

Authors: Chen, Fangyuan ^⁎, Liu, Ping, Bai, Ling, Li, Juanli, Chen, Tao

Source: In Archives of Cardiovascular Diseases March 2025 118(3):144-151

Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

Authors: Tiver, Kathryn D. ^{1, 2}, Chew, Derek P. ^{1, 3, 4}, Tan, Jia Y. ^{1, 2}, Lambrakis, Kristina ^{1, 3, 4}, De Pasquale, Carmine G. ^{1, 2}, Ganesan, Anand N. ^{1, 2, ∗}

Source: In Heart Rhythm O2 March 2025 6(3):299-306

SGLT2 inhibitors for alleviating heart failure through non-hypoglycemic mechanisms

Authors: Ya-ru Chen, Fang-yuan Zhu, Rong Zhou

Source: Frontiers in Cardiovascular Medicine, Vol 11 (2024)

Subject Terms: sodium-glucose cotransporter-2 inhibitor, non-diabetic, heart failure, cardiovascular outcome trials, empagliflozin, dapagliflozin, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2024.1494882/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/dc7e85f7127540db9f136847746333c7

Comparison of cardiovascular outcomes of new antihyperglycemic agents in Type 2 Diabetes Mellitus: a meta‐analysis

Authors: Zijing Zhou, Min Zheng, Zhihong Zuo, Ting Wu

Source: ESC Heart Failure, Vol 11, Iss 3, Pp 1647-1656 (2024)

Subject Terms: Cardiovascular outcomes, Sodium glucose cotransporter‐2 inhibitor, Glucagon‐like peptide 1 receptor agonist, Type 2 diabetes, Heart failure, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2055-5822

Access URL: https://doaj.org/article/5509a21845ba41ccb1191149c0c6d527

Are sodium-glucose co-transporter-2 inhibitors associated with improved outcomes in diabetic patients admitted to intensive care units with septic shock?

Authors: Nikita Ashcherkin, Abdelmohaymin A. Abdalla, Simran Gupta, Shubhang Bhatt, Claire I. Yee, Rodrigo Cartin-Ceba

Source: Acute and Critical Care, Vol 39, Iss 2, Pp 251-256 (2024)

Subject Terms: intensive care unit, mortality, septic shock, sodium-glucose cotransporter-2 inhibitor, type 2 diabetes mellitus, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

File Description: electronic resource

Relation: http://www.accjournal.org/upload/pdf/acc-2023-01046.pdf; https://doaj.org/toc/2586-6052; https://doaj.org/toc/2586-6060

Access URL: https://doaj.org/article/bc5127fe20734e92b7a0344b914d3613

Use of Sodium-Glucose Cotransporter-2 Inhibitors in Adults Aged ≥65 Years With Type 2 Diabetes and Cardiovascular Disease: A Cross-sectional Study of Different Drug Funding Policies

Authors: McCreary, Megan L. ^a, Yeung, Roseanne O. ^{a, b}, Manca, Donna P. ^c, Greiver, Michelle ^d, Singer, Alexander G. ^e, Lau, Darren ^{a, b, ∗}

Source: In Canadian Journal of Diabetes December 2024 48(8):524-530

Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis

Authors: Si-Qi Yang, Xi Zhao, Jing Zhang, Huan Liu, Yu-Han Wang, Yao-Guang Wang

Source: Frontiers in Endocrinology, Vol 15 (2024)

Subject Terms: diabetic kidney disease, sodium-glucose cotransporter-2 inhibitor, non-steroid mineralocorticoid receptor antagonists, network meta-analysis, cardiorenal, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fendo.2024.1429261/full; https://doaj.org/toc/1664-2392

Access URL: https://doaj.org/article/1e56d5cc64a34c0288eb3b564e8a18c8

Real-world Use and Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Diabetes and Heart Failure: A Population-level Cohort Study in Alberta, Canada

Authors: Butalia, Sonia ^{a, b, c, d, ∗}, Wen, Chuan ^e, Sigal, Ronald ^{a, b, c, d}, Senior, Peter ^{f, g}, Quan, Hude ^{c, d}, Chu, Luan Manh ^e, Yeung, Roseanne O. ^{f, g}, Kaul, Padma ^{g, h}

Source: In Canadian Journal of Diabetes July 2024 48(5):305-311

Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database

Authors: Go Anan, Daisuke Kikuchi, Kenji Omae, Takuo Hirose, Kouji Okada, Takefumi Mori

Source: Endocrine Journal, Vol 70, Iss 11, Pp 1103-1107 (2023)

Subject Terms: sodium-glucose cotransporter-2 inhibitor, urinary tract infection, epidemiological study, diabetes mellitus, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0317/_html/-char/en; https://doaj.org/toc/1348-4540

Access URL: https://doaj.org/article/24d8b2e3a13f4e5c925d213fc591d92c

Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial

Authors: Xue Yang, Zhiwei He, Li Yuan, Wenbin Huang, Doudou Li, Pingping Xiang, Yu Chen, Guofang Chen, Chao Liu

Source: BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-9 (2023)

Subject Terms: Canagliflozin, Type 2 diabetes mellitus, Remission, Metformin, Sodium-glucose cotransporter-2 inhibitor, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://doaj.org/toc/1472-6823

Access URL: https://doaj.org/article/359495b815de4e49a97703b2ecd0b129

Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs

Authors: Sean A. Newsom, Matthew M. Robinson

Source: Physiological Reports, Vol 12, Iss 11, Pp n/a-n/a (2024)

Subject Terms: aerobic, glucagon‐like peptide 1 receptor agonist, metformin, mitochondria, resistance, sodium‐glucose cotransporter‐2 inhibitor, Physiology, QP1-981

File Description: electronic resource

Relation: https://doaj.org/toc/2051-817X

Access URL: https://doaj.org/article/e765697ce5ab48b68063d60e2e32c8dd

Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level

Authors: Yi‐Wei Kao, Tze‐Fan Chao, Shao‐Wei Chen, Yu‐Wen Cheng, Yi‐Hsin Chan, Pao‐Hsien Chu

Source: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)

Subject Terms: estimated glomerular filtration rate, sodium–glucose cotransporter‐2 inhibitor, type 2 diabetes, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2047-9980

Access URL: https://doaj.org/article/e30c058b45694ede946aa7565772d72d

Effect of the sodium‐glucose cotransporter‐2 inhibitor, DWP16001, as an add‐on therapy to insulin for diabetic dogs: A pilot study

Authors: Ju‐Hyun An, Han‐Sol Choi, Ji‐Soo Choi, Hyun‐Woo Lim, Wan Huh, Ye‐In Oh, Joon Seok Park, Jumi Han, Soo Lim, Chae‐Young Lim, Tae‐Hee Kim, Jae‐Bong Moon, Hwa‐Young Youn

Source: Veterinary Medicine and Science, Vol 10, Iss 3, Pp n/a-n/a (2024)

Subject Terms: dogs, DWP16001, diabetes mellitus, sodium‐glucose cotransporter‐2 inhibitor, Veterinary medicine, SF600-1100

File Description: electronic resource

Relation: https://doaj.org/toc/2053-1095

Access URL: https://doaj.org/article/af8d7451080f4b62a64fb9a42473ce91

Selective sodium-glucose cotransporter-2 inhibitors in the improvement of hemoglobin and hematocrit in patients with type 2 diabetes mellitus: a network meta-analysis

Authors: Yuanyuan Luo, Ruojing Bai, Wei Zhang, Guijun Qin

Source: Frontiers in Endocrinology, Vol 15 (2024)

Subject Terms: selective sodium-glucose cotransporter-2 inhibitor, type 2 diabetes mellitus, network meta, hemoglobin, hematocrit, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fendo.2024.1333624/full; https://doaj.org/toc/1664-2392

Access URL: https://doaj.org/article/c4e905c42a0747a0a24150fedb6f81df